Northway Biotech is a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of biopharmaceuticals. The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.
Our state-of-the-art facilities in the EU and US include more than 40 R&D labs for CLD, USP, DSP, and analytical development, as well as cGMP manufacturing. Whether mammalian cell culture or microbial processing is optimal for your product's development, our cGMP facilities are equipped with separate production units to support the development and manufacturing of your drug substance and aseptic drug product.
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for the Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory TechnologyRead More
The largest biotech city in Europe will soon be built by Northway Healthcare Group, with an investment amounting to 7 billion eurosRead More